|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.240 BRL | -1.50% |
|
-0.57% | -12.08% |
| Nov. 05 | Dexco S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 | CI |
| Aug. 08 | Dexco S.A., Q2 2025 Earnings Call, Aug 07, 2025 |
Company Valuation: Dexco S.A.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 13,211 | 11,287 | 5,478 | 6,522 | 4,818 | 4,247 | - | - |
| Change | - | -14.56% | -51.47% | 19.06% | -26.13% | -11.86% | - | - |
| Enterprise Value (EV) 1 | 14,688 | 13,735 | 5,478 | 11,450 | 10,785 | 9,764 | 9,934 | 9,792 |
| Change | - | -6.49% | -60.12% | 109.03% | -5.81% | -9.47% | 1.74% | -1.43% |
| P/E ratio | 29.3x | 6.04x | 6.66x | 8.26x | 27.9x | 44.7x | 13.1x | 8.66x |
| PBR | 2.55x | 1.66x | - | 1.02x | 0.69x | 0.63x | 0.6x | 0.57x |
| PEG | - | 0x | -0.1x | -2.07x | -0.4x | -1x | 0x | 0.2x |
| Capitalization / Revenue | 2.25x | 1.38x | 0.65x | 0.88x | 0.59x | 0.51x | 0.49x | 0.46x |
| EV / Revenue | 2.5x | 1.68x | 0.65x | 1.55x | 1.31x | 1.18x | 1.14x | 1.07x |
| EV / EBITDA | 11.4x | 6.28x | 3.16x | 8.22x | 6.54x | 5.9x | 5.47x | 4.91x |
| EV / EBIT | 22x | 7.26x | 3.78x | 9.02x | 11.5x | 11.5x | 10.3x | 8.71x |
| EV / FCF | 13.7x | 15.1x | - | 64.6x | -103x | 75.7x | 18.4x | 13.2x |
| FCF Yield | 7.32% | 6.63% | - | 1.55% | -0.97% | 1.32% | 5.42% | 7.6% |
| Dividend per Share 2 | 0.2598 | 1.164 | - | 0.2153 | 0.0462 | 0.0264 | 0.0657 | 0.1672 |
| Rate of return | 1.64% | 8.56% | - | 2.67% | 0.78% | 0.5% | 1.25% | 3.19% |
| EPS 2 | 0.5398 | 2.25 | 1.018 | 0.9772 | 0.2133 | 0.1172 | 0.3996 | 0.6053 |
| Distribution rate | 48.1% | 51.7% | - | 22% | 21.7% | 22.5% | 16.4% | 27.6% |
| Net sales 1 | 5,880 | 8,170 | 8,487 | 7,383 | 8,235 | 8,290 | 8,722 | 9,172 |
| EBITDA 1 | 1,288 | 2,188 | 1,732 | 1,393 | 1,650 | 1,656 | 1,815 | 1,993 |
| EBIT 1 | 667.8 | 1,891 | 1,449 | 1,270 | 936.5 | 851.4 | 969 | 1,124 |
| Net income 1 | 453.8 | 1,725 | 764.9 | 811.3 | 174.4 | 97.02 | 429.4 | 628.5 |
| Net Debt 1 | 1,477 | 2,448 | - | 4,929 | 5,967 | 5,518 | 5,688 | 5,546 |
| Reference price 2 | 15.818 | 13.600 | 6.780 | 8.070 | 5.960 | 5.240 | 5.240 | 5.240 |
| Nbr of stocks (in thousands) | 835,151 | 829,912 | 807,921 | 808,142 | 808,365 | 810,405 | - | - |
| Announcement Date | 2/8/21 | 2/9/22 | 3/8/23 | 3/6/24 | 3/13/25 | - | - | - |
1BRL in Million2BRL
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 45.4x | 1.19x | 5.94x | 0.5% | 797M | |
| 38.36x | 2.21x | 14.06x | 1.31% | 5.86B | |
| 14x | 1.75x | 9.67x | 1.44% | 3.38B | |
| 58.84x | 3.67x | 29.43x | 0.18% | 1.98B | |
| 13.69x | - | - | 5.81% | 1.55B | |
| 14.89x | 1.12x | 6.64x | 4.75% | 1.02B | |
| 20.48x | 2.15x | 9.64x | 3.6% | 686M | |
| 29.23x | 1.5x | 14.93x | 0.25% | 393M | |
| Average | 29.36x | 1.94x | 12.90x | 2.23% | 1.96B | |
| Weighted average by Cap. | 31.06x | 2.14x | 13.98x | 1.9% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- DXCO3 Stock
- Valuation Dexco S.A.
Select your edition
All financial news and data tailored to specific country editions
